Please provide your email address to receive an email when new articles are posted on . More thorough understanding of giant cell arteritis disease processes has shed light on how immune checkpoint ...
Auto-reactive antibodies as predictive markers for immune checkpoint–induced pneumonitis. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not include a full ...
Nivolumab treatment in advanced non-small cell lung cancer (NSCLC): Retrospective analysis of real-life data in the Hospital Universitario Reina Sofía (HURS). This is an ASCO Meeting Abstract from the ...
Immune checkpoint inhibitors (ICIs) are a type of immunotherapy or cancer treatment that targets specific immune cells known as T cells, which are responsible for eliminating infection. In cancer, T ...
Combination therapies, which target multiple immune checkpoints at once, have the potential to deliver improved outcomes for cancer patients. The development of clinically relevant predictive tools to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results